Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study.

Syrios J1, Kouroussis C1, Kotsakis A1, Kentepozidis N1, Kontopodis E1, Kalbakis K1, Vardakis N1, Hatzidaki D1, Polyzos A1, Georgoulias V2; GU Working Group of the Hellenic Oncology Research Group (HORG), Athens, Greece.

Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)

Asimakopoulou N, Souglakos J, Kentepozidis N, Karampeazis A, Kotsakis A, Ziras N, Makrantonakis P, Prinarakis E, Vamvakas L, Georgoulias V

Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)

ISO-CC-005; a phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer

G. Carlsson, T.K. Guren, J. Haux, P. Pfeiffer, H. Taflin1, D. Mavroudis, V. Georgoulias, C. Papadimitriou, N. Kentepozidis, D. Boumpas, L. Skintemo1, K. Ganlöv, B. Gustavsson

Διεθνείς Δημοσιεύσεις

Prognostic Significance of IGF-1 Signalling Pathway in Patients With Advanced Non-small Cell Lung Cancer. Kotsantis I1, Economopoulou P1, Psyrri A2, Maratou E3, Pectasides D4, Gogas H5, Kentepozidis N6, Mountzios G6, Dimitriadis G7, Giannouli…